These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24646320)

  • 1. Association of physical activity with glycaemic control and cardiovascular risk profile in 65 666 people with type 2 diabetes from Germany and Austria.
    Hermann G; Herbst A; Schütt M; Kempe HP; Krakow D; Müller-Korbsch M; Holl RW;
    Diabet Med; 2014 Aug; 31(8):905-12. PubMed ID: 24646320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
    Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
    Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Physical Activity on Glycemic Control and Prevalence of Cardiovascular Risk Factors in Adults With Type 1 Diabetes: A Cross-sectional Multicenter Study of 18,028 Patients.
    Bohn B; Herbst A; Pfeifer M; Krakow D; Zimny S; Kopp F; Melmer A; Steinacker JM; Holl RW;
    Diabetes Care; 2015 Aug; 38(8):1536-43. PubMed ID: 26015557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The joint association of physical activity and glycaemic control in predicting cardiovascular death and all-cause mortality in the US population.
    Reddigan JI; Riddell MC; Kuk JL
    Diabetologia; 2012 Mar; 55(3):632-5. PubMed ID: 22080254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
    Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
    Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.
    Barrot-de la Puente J; Mata-Cases M; Franch-Nadal J; Mundet-Tudurí X; Casellas A; Fernandez-Real JM; Mauricio D
    Int J Clin Pract; 2015 Dec; 69(12):1486-95. PubMed ID: 26422335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control in people with diabetes influences the beneficial role of physical activity on cardiovascular mortality. Prospective data from the HUNT Study, Norway.
    Moe B; Midthjell K; Nilsen TI
    Prim Care Diabetes; 2015 Dec; 9(6):451-7. PubMed ID: 26001311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.
    Hove KD; Brøns C; Færch K; Lund SS; Petersen JS; Karlsen AE; Rossing P; Rehfeld JF; Vaag A
    Diabetologia; 2013 Jan; 56(1):22-30. PubMed ID: 23011351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
    Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
    Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK.
    Oluwatowoju I; Abu E; Wild SH; Byrne CD
    Diabet Med; 2010 Mar; 27(3):354-9. PubMed ID: 20536500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
    Becker A; van der Does FE; van Hinsbergh VW; Heine RJ; Bouter LM; Stehouwer CD
    Neth J Med; 2003 Apr; 61(4):129-36. PubMed ID: 12852722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
    Khan HA; Sobki SH; Khan SA
    Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
    Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
    Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.